2011 News Releases

2013 | 2012 | 2011

Date Title   11/14/11 Luminex Corporation Vice President of Biodefense to Speak at DTRA'S 2011 CBD S&T Conference Dr. Amy Altman's Presentation to Focus on the Benefits of Multiplexing for Biothreat and Infectious Disease Detection AUSTIN, Texas, Nov. 14, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (NASDAQ: LMNX) today announced Dr. Amy Altman, vice president of Biodefense will present at the Defense Threat Reduction Agency's (DTRA) 2011 Chemical and Biological Defense Science and Technology (CBD S&T) Conference, which takes place November 14-16, 2011 in Las Vegas, Nevada. (Logo: http://...  11/01/11 Luminex Corporation Reports Third Quarter 2011 Results Revenue Growth of 34 percent over prior year AUSTIN, Texas, Nov. 1, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (NASDAQ: LMNX) today announced financial results for the third quarter ended September 30, 2011. Financial and operating highlights include the following: (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Consolidated third quarter revenue was $45.6 million, a 34% increase over the third quarter of 2010 Third quarter 2011 assay sales of $1...  10/19/11 Luminex Corporation Receives Deloitte Technology Fast 500(TM) Award Luminex Recognized as One of the Fastest Growing Companies in North America AUSTIN, Texas, Oct. 19, 2011 /PRNewswire via COMTEX/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has been recognized in Deloitte's 2011 Technology Fast 500(TM), a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on comparing percentage revenue growth over five years from 2006-2010. (Logo: http:...  10/11/11 Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011 AUSTIN, Texas, Oct. 11, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the third quarter of 2011 on Tuesday, November 1, 2011. A press release announcing the results is scheduled for release after the close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Management will hold a conference call to discuss the operating highlights and financial results for the third quarter ended September ...  10/05/11 Luminex Corporation Joins Forces with the National Marrow Donor Program - Be The Match® More Than 100 Employees Become Registered Donors and Luminex Provides Title Sponsorship for 17th Annual Marrow Ambassadors Golf Tournament AUSTIN, Texas, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Luminex Corporation (NASDAQ: LMNX) announced today that it has joined forces with the National Marrow Donor Program - Be The Match to raise awareness of the need for additional donors to increase the chances of finding a match for the growing number of patients awaiting life-saving bone marrow trans...  09/26/11 Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna Two-Day Multiplexing Symposium Brings Together Leading Scientists to Discuss New Developments in Clinical Diagnostics and Life Science Research AUSTIN, Texas, Sept. 26, 2011 /PRNewswire via COMTEX/ -- Luminex Corporation (NASDAQ: LMNX), today announced that it will host Planet xMAP Europe 2011, its annual European multiplexing technology symposium, September 28-29, 2011, at The Hofburg in Vienna, Austria. The event will feature scientific sessions, workshops, discussion groups, exhibitions and...  08/30/11 Luminex Corporation to Present at Upcoming Investment Conferences In September AUSTIN, Texas, Aug. 30, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (Nasdaq: LMNX) announced today that management will present at two upcoming investment conferences, the Morgan Stanley Global Healthcare Conference and the UBS Global Life Sciences Conference, both scheduled to take place in New York City. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Patrick J. Balthrop, president and chief executive officer, will present at the Morgan Stanley Global Healthcare ...  08/08/11 Luminex Corporation Reports Second Quarter 2011 Results Revenue Growth of 43 Percent Over Prior Year AUSTIN, Texas, Aug. 8, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (NASDAQ: LMNX) today announced financial results for the second quarter ended June 30, 2011. Financial and operating highlights include the following: (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Consolidated second quarter revenue was $47.6 million, a 43% increase over the second quarter of 2010 Second quarter 2011 consumable sales ...  07/19/11 Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test xTAG® RVP FAST Delivers 96 Actionable Patient Results in a Few Hours by Testing for Multiple Viral Strains and Subtypes Causing Respiratory Viral Infections AUSTIN, Texas, July 19, 2011 – Luminex Corporation (Nasdaq: LMNX) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its xTAG Respiratory Viral Panel FAST (RVP FAST). This front line test has the potential to significantly change the way respiratory viral testing is performed and comp...  07/18/11 Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011 AUSTIN, Texas, July 18, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the second quarter of 2011 on Monday, August 8, 2011. A press release announcing the results is scheduled for release after the close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Management will hold a conference call to discuss the operating highlights and financial results for the second quarter and six months en...  06/27/11 Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc. AUSTIN, Texas, June 27, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (NASDAQ: LMNX) today announced the completion of its acquisition of privately-held EraGen Biosciences, Inc., an innovator in molecular diagnostic testing technologies for infectious disease and genetic applications, for $34 million in cash. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Luminex expects the EraGen acquisition will add between $5 million and $7 million to 2011 consolidated revenue. ...  06/23/11 Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System Austin Biotech Receives Two Stevie® Awards for Innovation at Ninth Annual American Business Awards AUSTIN, Texas, June 23, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (NASDAQ: LMNX) has won two American Business Awards - Stevie Awards - Most Innovative Company of the Year (for companies with less than 2,500 employees) and Business Innovation of the Year for the MAGPIX System. A record number of nominations were submitted this year with more than 2,800 organizations from virtually all ...  06/21/11 Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc. Acquisition Expands Molecular Diagnostic and Infectious Disease Capabilities AUSTIN, Texas, June 21, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (NASDAQ: LMNX) today announced a definitive agreement to acquire privately-held EraGen Biosciences, Inc., an innovator in molecular diagnostic testing technologies for infectious disease and genetic applications. Under the terms of the agreement Luminex will purchase all outstanding shares of EraGen for approximately $34 million in cash, subj...  06/08/11 Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis New CE Marked xTAG® Gastrointestinal Pathogen Panel (GPP) Used to Triage Patients at German Kliniken der Stadt Köln AUSTIN, Texas, and KÖLN, Germany, June 8, 2011 /PRNewswire via COMTEX/ - Luminex Corporation (NASDAQ: LMNX) and the Kliniken der Stadt Köln, Institute of Pathology and Institute for Hygiene today announced that Luminex’s newly released xTAG® Gastrointestinal Pathogen Panel (GPP) is being used successfully as a first-line screen for patients at Kliniken der Stadt Köln suspected of...  06/01/11 Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument MAGPIX System Brings Affordable Multiplexing to Laboratories Worldwide AUSTIN, Texas, June 1, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (NASDAQ: LMNX), today announced it has signed a global sales and distribution agreement with Life Technologies Corporation (NASDAQ: LIFE) for its award-winning MAGPIX multiplexing instrument for analysis of proteins for research use. Launched in July 2010, MAGPIX is a compact multiplex analyzer that can quickly, accurately and reproducibly detect 50 ...  05/31/11 Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference AUSTIN, Texas, May 31, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (Nasdaq: LMNX) today announced that management will present at the Jefferies 2011 Global Healthcare Conference to be held June 6-9 in New York. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 9:00 a.m. Eastern time on Tuesday, June 7, 2011. The presentation will be webcast live and may be accessed ...  05/09/11 Luminex Corporation Reports First Quarter 2011 Results Revenue Growth of 30 percent over prior year AUSTIN, Texas, May 9, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (NASDAQ: LMNX) today announced financial results for the first quarter ended March 31, 2011. Financial and operating highlights include the following: Consolidated first quarter revenue was $43.3 million, a 30 percent increase over the first quarter of 2010 First quarter 2011 consumable sales of $15.0 million, a 53 percent increase over the first quarter o...  05/05/11 New CE Marked Test Simultaneously Detects Up To 95% of Gastrointestinal Infections in Under Five Hours Luminex xTAG® Gastrointestinal Pathogen Panel (GPP) delivers clinically actionable results in time to affect patient care AUSTIN, Texas and MILAN, May 5, 2011 /PRNewswire via COMTEX/ -- Luminex Corporation (NASDAQ: LMNX) announced today that it has received CE marking for its new xTAG Gastrointestinal Pathogen Panel (GPP).This innovative assay is the first test of its kind to help identify up to 95 percent of the disease causing pathogens in a single test. It delivers the highest number of...  04/18/11 Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011 AUSTIN, Texas, April 18, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (Nasdaq: LMNX) today announced that it expects to report results for the first quarter of 2011 on Monday, May 9, 2011. A press release announcing the results is scheduled for release after the close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Management will hold a conference call to discuss the operating highlights and financial results for the first quarter ended March 31, 2011, o...  04/07/11 Luminex Corporation Wins Prestigious Medical Design Excellence Award MAGPIX(R) System Recognized in In Vitro Diagnostics Category for Innovative Design and Contribution AUSTIN, Texas, April 7, 2011 /PRNewswire via COMTEX/ -- Luminex Corporation (Nasdaq: LMNX) has won a 2011 Medical Design Excellence Award in the category of In Vitro Diagnostics for its innovative MAGPIX®  system. Introduced in 2010, MAGPIX is a compact, versatile laboratory analysis platform designed to improve productivity by delivering multiple highly accurate, reproducible results fro...  03/02/11 Luminex Corporation to Present at Cowen and Company's 31st Annual Health Care Conference AUSTIN, Texas, March 2, 2011 /PRNewswire via COMTEX/ -- Luminex Corporation (Nasdaq: LMNX) today announced that senior management will present at the 31st Annual Health Care Conference to be held March 7 -9, 2011, in Boston, MA. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 1:20 p.m. Eastern time on Tuesday, March 8, 2011. The presentation will be webcast live and may be...  02/22/11 Luminex Corporation Ranked One of the 25 Fastest-Growing Technology Companies in America by Forbes for Third Consecutive Year AUSTIN, Texas, Feb. 22, 2011 /PRNewswire via COMTEX/ -- Luminex Corporation (Nasdaq: LMNX), today announced for the third consecutive year it has been named one of the 25 Fastest-Growing Technology Companies in America by Forbes. Luminex technology helps clinicians and researchers discover and pinpoint the cause of diseases and infections, create new medical therapies, identify genetic diseases and protect the public from bio-threats through its xMAP® Technology. (Logo: http://photos.prnews...  02/15/11 Luminex and Partners HealthCare Announce Collaboration Agreement Collaborative Efforts Aimed at Translating Biomarker Discoveries Into Novel Molecular Diagnostic Tests AUSTIN, Texas, Feb. 15, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (Nasdaq: LMNX) announced today that it has teamed with Partners HealthCare toward the discovery of novel biomarkers and development of clinical assays. This program will enable Partners HealthCare Center for Personalized Genetic Medicine (PCPGM) to develop novel molecular diagnostic assays based on biomarkers discover...  02/07/11 Luminex Corporation Reports Fourth Quarter and Full Year 2010 Results Luminex achieves record fourth quarter revenue; 17 percent annual growth AUSTIN, Texas, Feb. 7, 2011 /PRNewswire via COMTEX/ -- Luminex Corporation (Nasdaq: LMNX) today announced financial results for the fourth quarter and year ended December 31, 2010. Recent financial and operating highlights include the following: Fourth quarter 2010 consolidated revenue was $41.2 million, an 8 percent increase over the fourth quarter of 2009; full year 2010 revenue was $141.6 million, a 17 percent...  01/18/11 Luminex Corporation Fourth Quarter and Full Year 2010 Earnings Release Scheduled for February 7, 2011 AUSTIN, Texas, Jan. 18, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (Nasdaq: LMNX) today announced that it expects to report results for the fourth quarter and full year 2010 on Monday, February 7, 2011. A press release announcing the results is scheduled for release after the close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Management will hold a conference call to discuss the operating highlights and financial results for the fourth quarter and fu...  01/05/11 Luminex Corporation to Present at JP Morgan Healthcare Conference AUSTIN, Texas, Jan. 5, 2011 /PRNewswire via COMTEX/ --Luminex Corporation (Nasdaq: LMNX) today announced that management will present at the 29th Annual JP Morgan Healthcare Conference to be held January 9 -13, 2011, in San Francisco, CA. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 10:00 a.m. Pacific time (1:00 p.m. Easterntime) on Wednesday, January 12, 2011. The prese...